TY  - JOUR
PY  - 2021//
TI  - Long-acting aripiprazole in the management of violence in treatment nonadherent schizophrenia
JO  - Primary care companion to CNS disorders
A1  - Miola, Alessandro
A1  - Toffanin, Tommaso
A1  - Pavan, Chiara
A1  - Comini, Francesco Folena
A1  - Salvati, Benedetta
A1  - Sambataro, Fabio
A1  - Pigato, Giorgio
SP  - e2623
EP  - e2623
VL  - 23
IS  - 1
N2  - The risk of violent behavior is higher in patients with schizophrenia relative to the general population. Violence can be prevented using antipsychotic drugs, with clozapine being the gold standard. Regrettably, the nonadherence rate for oral treatments is very high in schizophrenia, ranging from 40% to 80%, and it is one of the principal factors contributing to violent behavior.1 The introduction of atypical long-acting injectable (LAI) antipsychotics, with faster titration schemes and better tolerability, can improve treatment adherence. Preventing violent activity can reduce criminal behavior in patients with schizophrenia and allow for participation in rehabilitation programs.2 We report on the long-term effectiveness of aripiprazole LAI monotherapy in reducing criminal violent behavior in a treatment nonadherent patient with severe psychosis admitted to an acute ward per court-ordered commitment...<p />  <p>Language: en</p>
LA  - en
SN  - 2155-7772
UR  - http://dx.doi.org/10.4088/PCC.20l02623
ID  - ref1
ER  -